Yes, the encouraging idea that sales of the device during trials would defray costs hasn't made any noticeable impact on outgoings
Yes, the encouraging idea that sales of the device during trials...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.18 |
Change
-0.020(0.15%) |
Mkt cap ! $278.8M | |||
| Open | High | Low | Value | Volume |
| $13.23 | $13.23 | $13.01 | $64.47K | 4.934K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 717 | $13.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.18 | 147 | 1 |
View Market Depth
| Last trade - 11.02am 02/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |